Jacqueline D. Wang

Jacqueline D. Wang

Auto-generated profile, based on publicly available information

Jacqueline D. Wang

University of Pittsburgh School of Medicine Pittsburgh US

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
BRBrigida Rusconi
Brigida Rusconi
ABAdina K. Bard
Adina K. Bard
RMRyan McDonough
Ryan McDonough
AKAngel M. Kindsvogel
Angel M. Kindsvogel
JWJacqueline D. Wang
Jacqueline D. Wang
PTPhillip I. Tarr
Phillip I. Tarr
Maternal immunoglobulins of the class G (IgGs) protect offspring from enteric infection, but when, where, and how these antibodies are physiologically generated and confer protection remains enigmatic. We found that circulating IgGs in adult mice preferentially bind early-life gut commensal bacteria over their own adult gut commensal bacteria. IgG-secreting plasma cells specific for early-life gut bacteria appear in the intestine soon after weaning, where they remain into adulthood. Manipulating exposure to gut bacteria or plasma cell development before, but not after, weaning reduced IgG-secreting plasma cells targeting early-life gut bacteria throughout life. Further, the development of this anti-gut commensal IgG response coincides with the early-life interval in which goblet cell–associated antigen passages (GAPs) are present in the colon. Offspring of dams “perturbed” by B cell ablation or reduced bacterial exposure in early life were more susceptible to enteric pathogen challenge. In contrast to current concepts, protective maternal IgGs targeted translocating gut commensals in the offspring, not the enteric pathogen. These early-life events affecting anti-commensal IgG production have intergenerational effects for protection of the offspring.

1 April 2025 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
SUSreeram Udayan
Sreeram Udayan
AFAlexandria N. Floyd
Alexandria N. Floyd
VJVini John
Vini John
BBBibiana E. Barrios
Bibiana E. Barrios
BRBrigida A. Rusconi
Brigida A. Rusconi
RNRodney D. Newberry
Rodney D. Newberry

7 September 2026 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
PDF file
NANana‐Hawwa Abdul‐Rahman
Nana‐Hawwa Abdul‐Rahman
JWJacqueline D. Wang
Jacqueline D. Wang
MMMiriam Motlak
Miriam Motlak
GGGerardo Guiltarte
Gerardo Guiltarte
RPReethi S. Padmanabhan
Reethi S. Padmanabhan
SCSonal Choudhary
Sonal Choudhary
Background: Omega fatty acids, including polyunsaturated omega‐3 and omega‐6 fatty acids (PUFAs) and monounsaturated omega‐9 fatty acids, regulate inflammation, cellular signaling, and tissue homeostasis, and may influence hair follicle biology and hair growth. The widespread use of dietary supplements for hair loss has been fueled by increasing consumer interest and the rapid spread of health information on social media. Aims: This scoping review synthesizes preclinical and clinical evidence on the role of omega fatty acids in the management of alopecia. Methods: PubMed, Embase, ClinicalTrials.gov , the Cochrane Library, and Ovid MEDLINE were searched from database inception through February 2, 2026. The review was conducted in accordance with the PRISMA‐ScR. Eligible studies were peer‐reviewed, English‐language studies evaluating the relationship between omega fatty acids and hair growth, hair loss, or hair follicle biology in scarring or nonscarring alopecia. Results: Preclinical studies suggest that omega fatty acids may promote dermal papilla cell proliferation, activate signaling pathways involved in hair follicle growth, suppress mediators of androgen‐driven hair loss, and may protect against chemotherapy‐induced follicular apoptosis. Clinical studies have reported improvements in hair density, hair growth, and reduced shedding, although many studies evaluated combination nutritional supplements rather than omega fatty acids alone. In contrast, one clinical study of men with androgenetic alopecia found that higher omega‐3 intake was associated with a lower likelihood of clinical improvement. Limited clinical evidence also suggests that omega fatty acid supplementation may support hair regrowth in alopecia areata through immunomodulatory and anti‐inflammatory effects. Conclusion: Current data do not support omega fatty acid supplementation as a standalone treatment for any alopecia subtype.

25 September 2025 in Research Square
Verified
Preprint
Open access
PDF file
RNRodney Newberry
Rodney Newberry
VJVini John
Vini John
BBBibiana Barrios
Bibiana Barrios
JWJacqueline Wang
Jacqueline Wang
SUSreeram Udayan
Sreeram Udayan
BRBrigida Rusconi
Brigida Rusconi
Invariant Natural Killer T (iNKT) cells recognize glycolipid antigens presented on CD1d and rapidily respond to direct immune responses. iNKT cells develop in the thymus and migrate to peripheral tissues in what has been presumed to be differentiated/committed states. Accordingly, colonic iNKT cells are established in early life, considered to remain ‘fixed’ post-weaning, and determine life-long colitis susceptibility. Using single cell RNA sequencing (scRNA-seq), we demonstrate that humans and mice contain colonic iNKT populations transcriptionally resembling immature and intermediate thymic iNKT precursors. Contrary to prevailing paradigms, we demonstrate colonic iNKT cell populations expand in adult mice when CD1d expressing colonic goblet cells form goblet cell-associated antigen passages. Expansion preferentially affected intermediate iNKT cells, was durable, and protective in a colitis model. These studies reveal that the adult colon harbors iNKT cells with retained plasticity and uncover a novel role for goblet cells as unconventional antigen presenting cells regulating this axis.